CompoAtlas

KAMA GOLD-UP SPRAY

Natural health product licensed in Canada

Licence holder
Nanz Life Science Inc.
NPN or DIN-HM
80059054
Status
Active licence
Licence date
23 March 2015
Revision date
Not provided
Form
Vaporisateur
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Asparagus racemosus

Source : Racine

Extraction ratio : 1:30

Dry plant equivalent : 5 milligramme

150 milligramme
Anacyclus pyrethrum

Source : Racine

Extraction ratio : 1:10

Dry plant equivalent : 10 milligramme

100 milligramme
Celastrus paniculatus

Source : Graine(s)

Extraction ratio : 1:10

Dry plant equivalent : 2.5 milligramme

25 milligramme
Withania somnifera

Source : Racine

Extraction ratio : 1:20

Dry plant equivalent : 5 milligramme

100 milligramme
Acide 4-aminobenzoïque, Ester d'éthyle

Source : Benzocaine

5 %

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 3 Pulvérisateur ; maximum: 8 Pulvérisateurminimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

"KAMA GOLD-UP SPRAY" can be used for reducing oversensitivity in advance of intercourse. It can also be used for temporary male genital desensitisation, helping to slow the onset of ejaculation. Helps in temporarily retarding the onset of ejaculation/temporarily slowing the the onset of ejaculation/ temporarily prolonging the time until ejaculation. Kama Gold Up Spray also helps in the prevention of premature ejaculation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80059054

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line